{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:31:05Z","timestamp":1793943065421,"version":"4.8.0"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T00:00:00Z","timestamp":1228780800000},"content-version":"vor","delay-in-days":3722,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver"],"published-print":{"date-parts":[[1998,10]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> <jats:italic>Aims\/Background:<\/jats:italic> The clinical significance of GB virus\u2010C\/hepatitis G virus (GBV\u2010C\/HGV) infection in chronic hepatitis B is not well known and its role in the outcome of liver disease was investigated. <jats:italic>Methods:<\/jats:italic> HGV\u2010RNA and antibody to HGV (anti\u2010E2) were studied in 125 patients with chronic hepatitis B (41 with multiple hepatitis virus exposure), 82 asymptomatic HBsAg carriers and 103 healthy adults. <jats:italic>Results:<\/jats:italic> In chronic hepatitis B, HGV\u2010RNA was more frequent in patients with HDV infection and\/or anti\u2010HCV positivity than in those without (29% vs 6%, <jats:italic>p<\/jats:italic>&lt;0.0001), mainly in drug addicts (38%). At diagnosis the overall prevalence of any marker (HGV\u2010RNA plus anti\u2010E2) was similar in chronic hepatitis due to HBV alone (17%), in HBsAg carriers (16%) and in healthy adults (17%) and increased to 58% in those exposed to HDV and\/or HCV. During 1\u201311 years of follow\u2010up, HGV infection persisted in 70% of patients with chronic hepatitis B. About 40% of HGV persistently coinfected patients underwent sustained biochemical remission, whereas continuing disease activity was observed in 80% of patients who cleared HGV\u2010RNA. <jats:italic>Conclusions:<\/jats:italic> In chronic HBV infection the rate of exposure to HGV is similar to that in healthy adults, except for high risk patients. Long lasting HGV coinfection or anti\u2010E2 seroconversion did not modify the course of chronic hepatitis B.<\/jats:p>","DOI":"10.1111\/j.1600-0676.1998.tb00818.x","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T18:50:33Z","timestamp":1281466233000},"page":"360-365","source":"Crossref","is-referenced-by-count":6,"title":["Influence of GB virus\u2010C\/hepatitis G virus infection on the long\u2010term course of chronic hepatitis B"],"prefix":"10.1111","volume":"18","author":[{"given":"Giovanna","family":"Fattovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lisa","family":"Ribero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Favarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Azzario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Fasola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pantalena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Portera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,12,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0695-564"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<60::AID-JMV10>3.0.CO;2-A"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5248.505"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)06461-6"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703133361101"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703133361102"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601183340316"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80306-0"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80250-9"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80413-8"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-11-199706010-00004"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70139-2"},{"key":"e_1_2_1_14_2","first-page":"1992","article-title":"Serum hepatitis G virus RNA in patients with chronic viral hepatitis","volume":"92","author":"Marrone A.","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/323508a0"},{"key":"e_1_2_1_16_2","first-page":"3529","article-title":"A multicenter controlled, randomized, open trial of interferon alpha 2b treatment of anti\u2010human immunodeficiency virusnegative hemophilic patients with chronic hepatitis C","volume":"89","author":"Rumi M G","year":"1997","journal-title":"Blood"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840060203"},{"key":"e_1_2_1_18_2","first-page":"914","article-title":"Acute and chronic hepatitis revisited","volume":"2","author":"Bianchi L.","year":"1977","journal-title":"Lancet"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.6.1320"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.2.458"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37111298088052.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260635"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/515257"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199802)54:2<107::AID-JMV7>3.0.CO;2-A"}],"container-title":["Liver"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0676.1998.tb00818.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0676.1998.tb00818.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T09:25:44Z","timestamp":1698485144000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0676.1998.tb00818.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1111\/j.1600-0676.1998.tb00818.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0676.1998.tb00818.x","archive":["Portico"],"relation":{},"ISSN":["0106-9543","1600-0676"],"issn-type":[{"value":"0106-9543","type":"print"},{"value":"1600-0676","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}